Trial Profile
A feasibility study of chemotherapy with vinorelbine plus bevacizumab in elderly patients with non-small lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Vinorelbine (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 21 Jun 2011 New trial record